Skip to content

Adequacy and effectiveness of thromboembolic prophylaxis in multiple myeloma patients treated with inmunomodulatory drugs.

European Statement

Clinical Pharmacy Services

Author(s)

Alba María Fernández Varela, Laura López Sandomingo, Nieves Valcarce Pardeiro, Isaura Rodríguez Penín

Why was it done?

.

What was done?

.

How was it done?

.

What has been achieved?

.

What next?

.